Table 3a Outcome after first breast cancer in all patients in the CPM and surveillance group
Outcome | CPM group ( N =79) | Surveillance group ( N =69) | P -value |
|---|---|---|---|
Follow up after first breast cancer mean±s.e. (years) | 7.4±0.5 | 10.5±0.7 | 0.035 |
Contralateral breast cancer | |||
N (%) | 1a (1.3) | 32 (46.4) | <0.001 |
Time until occurrence (years) | 5.4 | 6.4±0.8 | |
Vital status, N (%) | |||
Alive, disease free | 73 (92.4) | 50 (72.5) | |
Alive, breast cancer | 1 (1.3) | 7 (10.1) | |
Alive, ovarian cancer | 2 (2.5) | 1 (1.4) | |
Deceased from breast cancer | 3 (3.8) | 8 (11.6) | |
Deceased from ovarian cancer | — (0.0) | 2 (2.9) | |
Deceased from other cancer | — (0.0) | 1 (1.4) | |
Recurrence, N (%) | |||
Local recurrence | 8 (10.1) | 12 (17.4) | 0.233 |
Regional recurrence | 1 (1.3) | 1 (1.4) | 1.000 |
Distant metastasis | 5 (6.3) | 9 (13.0) | 0.260 |
Interval between primary breast carcinoma and start of follow-up (Tables 3b and c) | 4.0±0.5 | 6.8±0.7 | 0.001 |
